期刊文献+

Perspectives on early-stage lung cancer identification and challenges to thoracic surgery

原文传递
导出
摘要 Lung cancer is one of the leading causes of cancer-related death worldwide with the long-term survival rate for stage I cancers treated with surgery reaching over 80%,but rapidly reducing as disease develops with stage III cancer patients presenting with a long-term survival rate of just 20%.Altliough surgery remains die most effective strategy for treating early stage lung cancers,screening and early diagnosis remain critical for improving prognosis in lung cancer.In addition to advancements in surgical techniques,die rapid development of artificial intelligence(AI),liquid biopsy,and other technologies in recent years has led to new breakthroughs in the diagnosis of this disease.Clinical application of neoadjuvant therapies using immune checkpoint inhibitors have also shown promise for improved efficacy in the treatment of early stage lung cancers.This editorial was designed to summarize the recent progress around the screening and diagnosis of early stage lung cancers and the challenges associated with various surgical strategies for treating these patients.
出处 《Chronic Diseases and Translational Medicine》 CSCD 2022年第2期79-82,共4页 慢性疾病与转化医学(英文版)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部